Lupin has received final USFDA approval to market Sildenafil tablets, used in the treatment of erectile dysfunction in USA. The drug is a generic version of Pfizer Inc’s Viagra tablets. It will act as phosphodiesterase-5 (PDE5) inhibitor and indicated for the treatment of erectile dysfunction (ED). According to market estimates, Sildenafil tablets USP, 25 mg, 50 mg, and 100 mg had annual sales of around USD 611 million in the US market.
Company Profile : Lupin Ltd
Leave a Reply